References
Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F et al Nat Genet 2010; 42: 448–453.
Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF et al Hum Mol Genet 2007; 16: 24–35.
Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA et al Hum Mol Genet 2007; 16: 36–49.
Saccone NL, Saccone SF, Hinrichs AL, Stitzel JA, Duan W, Pergadia ML et al Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 453–466.
Hoft NR, Corley RP, McQueen MB, Schlaepfer IR, Huizinga D, Ehringer MA . Neuropsychopharmacology 2009; 34: 698–706.
Payne TJ, Diefenbach L . Am J Med Sci 2003; 326: 212–215.
Perez-Stable EJ, Herrera B, Jacob P, Benowitz NL . JAMA 1998; 280: 152–156.
Fernander AF, Schumacher M, Nasim A . J Black Psychology 2008; 34: 49–69.
Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF et al Cancer Res 2009; 69: 6848–6856.
Li MD, Beuten J, Ma JZ, Payne TJ, Lou XY, Garcia V et al Hum Mol Genet 2005; 14: 1211–1219.
Li MD, Sun D, Lou XY, Beuten J, Payne TJ, Ma JZ . Mol Psychiatry 2007; 12: 462–473.
Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E et al Proc Natl Acad Sci USA 2010; 107: 5082–5087.
Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M et al Am J Hum Genet 2009; 85: 679–691.
Cho YS, Go MJ, Kim YJ, Heo JY, Oh JH, Ban HJ et al Nat Genet 2009; 41: 527–534.
Landi MT, Consonni D, Rotunno M, Bergen AW, Goldstein AM, Lubin JH et al BMC Public Health 2008; 8: 203.
Wang SS, Morton LM, Bergen AW, Lan EZ, Chatterjee N, Kvale P et al Hum Genet 2007; 122: 41–49.
Yoon D, Kim YJ, Cui WY, Van der Vaart A, Cho YS, Lee JY et al Hum Genet 2012; 131: 1009–1021.
Li MD, Yoon D, Lee JY, Han BG, Niu T, Payne TJ et al PLoS One 2010; 5: e12183.
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR . Genet Epidemiol 2010; 34: 816–834.
Howie BN, Donnelly P, Marchini J . PLoS Genet 2009; 5: e1000529.
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al Am J Hum Genet 2007; 81: 559–575.
Willer CJ, Li Y, Abecasis GR . Bioinformatics 2010; 26: 2190–2191.
Higgins JP, Thompson SG, Deeks JJ . BMJ 2003; 327: 557–560.
Pe'er I, Yelensky R, Altshuler D, Daly MJ . Genet Epidemiol 2008; 32: 381–385.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
Rights and permissions
About this article
Cite this article
Cui, W., Wang, S., Yang, J. et al. Significant association of CHRNB3 variants with nicotine dependence in multiple ethnic populations. Mol Psychiatry 18, 1149–1151 (2013). https://doi.org/10.1038/mp.2012.190
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2012.190
- Springer Nature Limited
This article is cited by
-
Significant association of the CHRNB3-CHRNA6 gene cluster with nicotine dependence in the Chinese Han population
Scientific Reports (2017)
-
Crucial roles of the CHRNB3–CHRNA6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research
Translational Psychiatry (2016)
-
Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions
Molecular Psychiatry (2016)
-
Evidence for Association Between Low Frequency Variants in CHRNA6/CHRNB3 and Antisocial Drug Dependence
Behavior Genetics (2016)
-
The contribution of rare and common variants in 30 genes to risk nicotine dependence
Molecular Psychiatry (2015)